Guardian Pharmacy Services, Inc. Class A (GRDN)
NYSE:GRDN
Want to see GRDN full AI Analyst Report?
GRDN Stock Chart & Stats
$37.54
$0.47(2.39%)
At close: 4:00 PM EST
$37.54
$0.47(2.39%)
Day’s Range― - ―
52-Week Range$19.17 - $43.11
Previous Close$20.98
Volume93.63K
Average Volume (3M)348.83K
Market Cap
$2.73B
Enterprise Value$2.43B
Total Cash (Recent Filing)$64.89M
Total Debt (Recent Filing)$36.88M
Price to Earnings (P/E)51.4
Beta0.52
Next Earnings
Aug 17, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.85
Shares Outstanding49,781,180
10 Day Avg. Volume450,542
30 Day Avg. Volume348,833
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)9.12
Price to Sales (P/S)1.30
P/FCF Ratio23.26
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue1.67
Enterprise Value/Gross Profit7.96
Enterprise Value/Ebitda23.70
Forecast
1Y Price Target
$43.00Price Target Upside14.54% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)1.26
Revenue Forecast (FY)$1.41B
Bulls Say, Bears Say
Bulls Say
Rapid Revenue Growth And Volume ExpansionSustained top-line acceleration and double-digit resident/script volume gains indicate durable organic growth and stronger market penetration. Persistent volume growth supports recurring revenue, scale economics, and provides a foundation for future margin recovery and cross‑sell opportunities.
Materially De-risked Balance Sheet And Extended LiquidityExtremely low leverage plus a multi-year revolver extension materially increases financial flexibility to fund M&A, greenfield growth, and working capital. Lower debt levels reduce insolvency risk and preserve capacity to absorb regulatory or margin shocks over the medium term.
Consistent Free Cash Flow And Strong Cash ConversionReliable free cash generation and high cash conversion underpin internal funding for acquisitions and investments, limit reliance on external capital, and strengthen resilience against margin pressure or temporary working capital swings.
Bears Say
IRA-driven Branded Pricing DisruptionA structural regulatory shock that sharply reduces branded pricing erodes per-script revenue and gross margins. Even with volume resilience, sustained lower pricing forces ongoing payor renegotiations, compresses long-term profitability, and raises execution risk versus peers.
Thin Margins And Acquisition Integration DragLow baseline margins limit sensitivity to revenue swings and reduce free-cashflow cushion. Continued margin dilution from recent acquisitions—expected through 2026–2027—can delay synergy realization and impede durable margin expansion despite strong revenue growth.
Earnings Volatility And Recurring One-time ItemsVolatile earnings and reliance on non-recurring adjustments complicate forecasting and weaken confidence in sustained profitability. Fluctuating ROE and periodic discrete items make it harder to assess trend performance and may mask underlying operational volatility.
Guardian Pharmacy Services, Inc. Class A News
GRDN FAQ
What was Guardian Pharmacy Services, Inc. Class A’s price range in the past 12 months?
Guardian Pharmacy Services, Inc. Class A lowest stock price was $19.17 and its highest was $43.11 in the past 12 months.
What is Guardian Pharmacy Services, Inc. Class A’s market cap?
Guardian Pharmacy Services, Inc. Class A’s market cap is $2.73B.
When is Guardian Pharmacy Services, Inc. Class A’s upcoming earnings report date?
Guardian Pharmacy Services, Inc. Class A’s upcoming earnings report date is Aug 17, 2026 which is in 66 days.
How were Guardian Pharmacy Services, Inc. Class A’s earnings last quarter?
Guardian Pharmacy Services, Inc. Class A released its earnings results on May 06, 2026. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.05.
Is Guardian Pharmacy Services, Inc. Class A overvalued?
According to Wall Street analysts Guardian Pharmacy Services, Inc. Class A’s price is currently Undervalued.
Does Guardian Pharmacy Services, Inc. Class A pay dividends?
Guardian Pharmacy Services, Inc. Class A does not currently pay dividends.
What is Guardian Pharmacy Services, Inc. Class A’s EPS estimate?
Guardian Pharmacy Services, Inc. Class A’s EPS estimate is 0.26.
How many shares outstanding does Guardian Pharmacy Services, Inc. Class A have?
Guardian Pharmacy Services, Inc. Class A has 49,781,180 shares outstanding.
What happened to Guardian Pharmacy Services, Inc. Class A’s price movement after its last earnings report?
Guardian Pharmacy Services, Inc. Class A reported an EPS of $0.29 in its last earnings report, beating expectations of $0.24. Following the earnings report the stock price went down -0.847%.
Which hedge fund is a major shareholder of Guardian Pharmacy Services, Inc. Class A?
Currently, no hedge funds are holding shares in GRDN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Guardian Pharmacy Services, Inc. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$43.00 (14.54% Upside)
$43.00 (14.54% Upside)
Hedge Fund Trend
Increased
By 249.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $419.2M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.50%
12-Months-Change
Fundamentals
Return on Equity
27.21%
Trailing 12-Months
Asset Growth
27.83%
Trailing 12-Months
Company Description
Guardian Pharmacy Services, Inc. Class A
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
GRDN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a positive operational and financial outturn for Q1 2026: the company successfully navigated major IRA-driven disruption, delivered revenue resilience, strong gross profit and adjusted EBITDA growth, and raised adjusted EBITDA guidance. Key risks remain, including a severe (~60%) branded pricing decline caused by the IRA, temporary working capital and payment-timing stresses, margin pressure from recent acquisitions (~80 bps drag), and potential cost headwinds from fuel and labor. Management emphasized scale advantages, proactive payor negotiations, and confidence in normalization of working capital, while noting that certain quarter-specific benefits are non-recurring. On balance, highlights demonstrating execution and financial strength outweigh the lowlights tied mainly to one-time disruptions and ongoing cost/legislative uncertainty.View all GRDN earnings summariesGRDN Stock 12 Month Forecast
Average Price Target
$43.00
▲(14.54% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---